SPIA
LGND icon

Steward Partners Investment Advisory’s Ligand Pharmaceuticals LGND Stock Holding History

Steward Partners Investment Advisory’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Hold
639
– – ﹤0.01% 2224
2026
Q1 		$128K Buy
639
+510
+395% +$101K ﹤0.01% 2245
2025
Q4 		$24.4K Buy
129
+24
+23% +$4.61K ﹤0.01% 3061
2025
Q3 		$18.6K Buy
105
+44
+72% +$6.54K ﹤0.01% 3121
2025
Q2 		$6.93K Hold
61
– – ﹤0.01% 3362
2025
Q1 		$6.41K Buy
+61
New +$6.9K ﹤0.01% 3295
2022
Q4 		– Sell
-160
Closed -$9K – 3425
2022
Q3 		$9K Hold
160
– – ﹤0.01% 2575
2022
Q2 		$9K Buy
160
+104
+186% +$5.9K ﹤0.01% 2559
2022
Q1 		$4K Sell
56
-1,069
-95% -$77.6K ﹤0.01% 2961
2021
Q4 		$108K Buy
1,125
+25
+2% +$2.31K ﹤0.01% 1566
2021
Q3 		$96K Buy
1,100
+125
+13% +$9.67K ﹤0.01% 1569
2021
Q2 		$80K Buy
975
+598
+159% +$49.7K ﹤0.01% 2552
2021
Q1 		$35.8K Buy
377
+186
+97% +$17.6K ﹤0.01% 2165
2020
Q4 		$12K Hold
191
– – ﹤0.01% 2241
2020
Q3 		$11K Hold
191
– – ﹤0.01% 2102
2020
Q2 		$13K Hold
191
– – ﹤0.01% 1935
2020
Q1 		$8K Sell
191
-1
-0.5% -$57 ﹤0.01% 1938
2019
Q4 		$12K Buy
192
+1
+0.5% +$67 ﹤0.01% 1953
2019
Q3 		$11K Buy
191
+56
+41% +$3.52K ﹤0.01% 1953
2019
Q2 		$9K Buy
+135
New +$9.94K ﹤0.01% 2030
2018
Q4 		– Sell
-231
Closed -$40K – 1542
2018
Q3 		$40K Buy
231
+96
+71% +$14.5K ﹤0.01% 1283
2018
Q2 		$17K Hold
135
– – ﹤0.01% 1532
2018
Q1 		$13K Buy
+135
New +$13.4K ﹤0.01% 1486
2017
Q3 		– Sell
-48
Closed -$3K – 1722
2017
Q2 		$3K Buy
48
+8
+20% +$560 ﹤0.01% 1344
2017
Q1 		$2K Buy
+40
New +$2.63K ﹤0.01% 1316

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's LGND Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 639 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2224.

Steward Partners Investment Advisory first reported a position in LGND in Q1 2017 and has held it in 25 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Steward Partners Investment Advisory held 639 shares of Ligand Pharmaceuticals worth $202K as of Q2 2026.
  • Steward Partners Investment Advisory left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2224 holding.
  • Steward Partners Investment Advisory first reported a position in Ligand Pharmaceuticals in Q1 2017 and has held it in 25 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.